Literature DB >> 9373595

Creutzfeldt-Jakob disease in the elderly.

R de Silva1, C Findlay, I Awad, R Harries-Jones, R Knight, R Will.   

Abstract

Creutzfeldt-Jakob disease (CJD) is typically described as a pre-senile dementia. However, cases do occur in the elderly and a case of sporadic CJD in an 86-year-old patient is described. The database of the UK national surveillance unit has been studied, and the age-specific incidences for various age groups over the period 1980-93 calculated. Cases of CJD in those over 80 years old have been identified and their clinical characteristics examined. There is no evidence that CJD presents atypically in the elderly, or that large numbers of cases are being missed in the elderly due to poor ascertainment.

Entities:  

Mesh：

Year:  1997        PMID： 9373595      PMCID： PMC2431436          DOI： 10.1136/pgmj.73.863.557

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

1.  Creutzfeldt-Jakob disease in Scotland and Northern Ireland 1980-1989.

Authors:  T G Esmonde; R G Will
Journal:  Scott Med J       Date:  1992-12       Impact factor: 0.729

2.  A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features.

Authors:  R G Will; W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

3.  Creutzfeldt-Jakob disease in Austria.

Authors:  J A Hainfellner; K Jellinger; H Diringer; M Guentchev; R Kleinert; P Pilz; H Maier; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

4.  Clinicopathological analysis of dementia disorders in the elderly.

Authors:  K Jellinger; W Danielczyk; P Fischer; E Gabriel
Journal:  J Neurol Sci       Date:  1990-03       Impact factor: 3.181

5.  Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.

Authors:  P Brown; C J Gibbs; P Rodgers-Johnson; D M Asher; M P Sulima; A Bacote; L G Goldfarb; D C Gajdusek
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

6.  Real and imagined clinicopathological limits of "prion dementia".

Authors:  P Brown; P Kaur; M P Sulima; L G Goldfarb; C J Gibbs; D C Gajdusek
Journal:  Lancet       Date:  1993-01-16       Impact factor: 79.321

7.  Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins.

Authors:  D Westaway; S J DeArmond; J Cayetano-Canlas; D Groth; D Foster; S L Yang; M Torchia; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

Review 8.  Neuropathology of spongiform encephalopathies in humans.

Authors:  J E Bell; J W Ironside
Journal:  Br Med Bull       Date:  1993-10       Impact factor: 4.291
  8 in total
  8 in total

1.  A Rare Case of Creutzfeldt-Jakob Disease With Alcohol Use Disorder and Review of Literature.

Authors:  Abraham Joseph; Hisham Mushtaq; George Zakhia; Jonathan Rohde; Adria Whiting; Abbas B Jama; Anwar Khedr; Nitesh K Jain; Syed Anjum Khan
Journal:  Cureus       Date:  2022-05-07

2.  Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center.

Authors:  André Karch; Lena Maria Raddatz; Claudia Ponto; Peter Hermann; David Summers; Inga Zerr
Journal:  J Neurol       Date:  2014-02-26       Impact factor: 4.849

Review 3.  Anaesthesia in elderly patients with neurodegenerative disorders: special considerations.

Authors:  Deborah A Burton; Grainne Nicholson; George M Hall
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Soluble Aβ aggregates can inhibit prion propagation.

Authors:  Claire J Sarell; Emma Quarterman; Daniel C-M Yip; Cassandra Terry; Andrew J Nicoll; Jonathan D F Wadsworth; Mark A Farrow; Dominic M Walsh; John Collinge
Journal:  Open Biol       Date:  2017-11       Impact factor: 6.411

5.  First participant diagnosed with Creutzfeldt-Jakob disease in the population-based Rotterdam Study was classified with mild cognitive impairment.

Authors:  Hata Karamujić-Čomić; Annemieke J M Rozemuller; M Arfan Ikram; Cornelia M van Duijn
Journal:  BMJ Case Rep       Date:  2021-03-29

6.  A Case of Rapidly Progressive Dementia.

Authors:  Arun Thekkekarott Kuruvila; Nishant Ranawat; Nikita Hegde; Alok Arora
Journal:  Cureus       Date:  2022-02-22

7.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

8.  Creutzfeldt-Jakob Disease: Analysis of Four Cases.

Authors:  Ali Al Balushi; Marshall W Meeks; Ghazala Hayat; Jafar Kafaie
Journal:  Front Neurol       Date:  2016-08-29       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.